Purple Biotech PPBT 深 沪
已收盘 12-12 16:00:00 美东时间
0.7516
-0.070
-8.56%
华盛通- 最 高0.7989
- 今 开0.7955
- 成交量 53.09万股
- 最 低 0.73
- 昨 收 0.822
- 总市值 678.72万
- 52周最高 5.20
- 市盈率 静 --
- 换手率 5.88%
- 52周最低 0.5326
- 委 比 80.87%
- 总股本 903.04万
- 历史最高 1390.00
- 量 比 0.23
- 振 幅 8.38%
- 历史最低 0.5326
- 每 手 1
- 风险率 1.07%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025
Purple Biotech Ltd. reported positive preclinical data for their CAPTN-3 tri-specific antibody platform at the ESMO IO Congress 2025. The platform demonstrated strong anti-tumor activity across two antibodies, IM1240 and IM1305, targeting different tumor antigens. IM1240 showed efficacy in PD-1-resistant models, while IM1305 validated the platform's adaptability. The NKG2A arm contributed significantly to immune activation, supported by transcrip...
12-11 12:00
Purple Biotech To Present New Preclinical Data From CAPTN-3 Platform Of Conditionally Activated Tri-Specific Antibodies At ESMO-IO 2025 Annual Congress
New data showcase the versatility and anti-tumor activity of the CAPTN-3 platform and its unique multi-arm design in treatment-resistant cancers REHOVOT, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Purple
12-04 20:10
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Addex Therapeutics (NASDAQ:ADXN) stock rose 12.1% to $8.18 during Mond...
11-25 05:05
Purple Biotech Unveils November 2025 Corporate Presentation Highlighting Oncology Advances
The latest update is out from Purple Biotech ( ($PPBT) ). On November 19, 2025,...
11-20 06:27
Purple Biotech Q3 EPADS $(0.29) Misses $(0.26) Estimate
Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.26) by 11.54 percent. This is a 25.64 percent increase over losses of $(0.39) per share from
11-14 21:25
Purple Biotech GAAP EPADS of -$0.86
Purple Biotech press release (PPBT): Q3 GAAP EPADS of -$0.86. Cash position of $10.5 million as of September 30, 2025, with an anticipated cash runway into the first half of 2027, supporting the devel...
11-14 21:12
Purple Biotech shares are trading higher after the company achieved a commercially viable yield for IM1240, positioning the program for future development.
Purple Biotech shares are trading higher after the company achieved a commercia...
10-29 19:34
Purple Biotech announces receipt of Nasdaq minimum bid price notification
Purple Biotech Ltd (NASDAQ:PPBT) said on Monday it received a notice from Nasdaq that its American Depositary Shares (ADSs) have been below the $1 minimum bid price required for continued listing for ...
10-21 04:08
Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification
Purple Biotech Ltd. received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement of $1.00 per share for 30 consecutive trading days. The company has until April 14, 2026, to regain compliance, and if unsuccessful, may have an additional 180 days to meet requirements. The company will monitor its ADS closing bid price and may consider options such as adjusting the ADS-to-ordinary share ratio to address the issue.
10-20 20:00
Purple Biotech Enters New ATM Agreement with H.C. Wainwright
The latest announcement is out from Purple Biotech ( ($PPBT) ). On September 19...
09-20 05:39
